Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma.
J Immunother Cancer. 2021 Jan;9(1):e001781. doi: 10.1136/jitc-2020-001781.
J Immunother Cancer. 2021.
PMID: 33500258
Free PMC article.
Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.
Alwan LM, Grossmann K, Sageser D, Van Atta J, Agarwal N, Gilreath JA.
Alwan LM, et al.
Target Oncol. 2014 Mar;9(1):63-71. doi: 10.1007/s11523-013-0276-7. Epub 2013 Apr 23.
Target Oncol. 2014.
PMID: 23609056
Item in Clipboard
Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients.
Gilreath JA, Sageser DS, Jorgenson JA, Rodgers GM.
Gilreath JA, et al. Among authors: sageser ds.
J Natl Compr Canc Netw. 2008 Jul;6(6):577-84. doi: 10.6004/jnccn.2008.0044.
J Natl Compr Canc Netw. 2008.
PMID: 18597711
Item in Clipboard
Alveolar epithelial cell plasminogen activator. Characterization and regulation.
Marshall BC, Sageser DS, Rao NV, Emi M, Hoidal JR.
Marshall BC, et al. Among authors: sageser ds.
J Biol Chem. 1990 May 15;265(14):8198-204.
J Biol Chem. 1990.
PMID: 2110565
Free article.
Item in Clipboard
Cite
Cite